Baker Bros. Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $674M | Buy |
|
|||||
|
2025
Q3 | $376M | Hold |
|
|||||
|
2025
Q2 | $290M | Buy |
|
|||||
|
2025
Q1 | $164M | Hold |
|
|||||
|
2024
Q4 | $241M | Hold |
|
|||||
|
2024
Q3 | $284M | Buy |
|
|||||
|
2024
Q2 | $179M | Hold |
|
|||||
|
2024
Q1 | $241M | Hold |
|
|||||
|
2023
Q4 | $153M | Buy |
|
|||||
|
2023
Q3 | $66M | Buy |
|
|||||
|
2023
Q2 | $101M | Buy |
|
|||||
|
2023
Q1 | $85.3M | Hold |
|
|||||
|
2022
Q4 | $71.9M | Hold |
|
|||||
|
2022
Q3 | $62.7M | Hold |
|
|||||
|
2022
Q2 | $56.7M | Buy |
|
|||||
|
2022
Q1 | $101M | Hold |
|
|||||
|
2021
Q4 | $151M | Hold |
|
|||||
|
2021
Q3 | $140M | Buy |
|
|||||
|
2021
Q2 | $95M | Hold |
|
|||||
|
2021
Q1 | $76.1M | Hold |
|
|||||
|
2020
Q4 | $121M | Hold |
|
|||||
|
2020
Q3 | $63.3M | Buy |
|